News

Drug company breaks 30 year agreement on patient advertising

BMJ 2001; 323 doi: 10.1136/bmj.323.7311.470/a (Published 1 September 2001)
Cite this as: BMJ 2001;323:470.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Carl Kovac
  1. Budapest

    Criticism has erupted in the United States against drug companies that, in violation of a 30 year old international marketing agreement, have begun aiming their advertising of potentially addictive drugs (used to treat children's behavioural and emotional problems) directly at parents, rather than just doctors.

    Among those companies is a UK firm, Celltech Pharma, whose US subsidiary, Celltech Pharmaceuticals (based in Rochester, New York), …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular